Emerging roles for novel antipsychotic medications in the treatment of schizophrenia

C. Anderson, M. Chakos, R. Mailman, J. Lieberman

Research output: Contribution to journalArticlepeer-review

24 Scopus citations

Abstract

Antipsychotic medications are the mainstay of treatment for schizophrenia. The recent advent the atypical antipsychotic has provided new clinical options and sets higher expectations for the treatment of schizophrenia. It is not yet clear how each different drug will fit within the therapeutic armamentarium and this lack is most evident with considering patients with treatment refractory schizophrenia. On the other hand, the expectation of superior efficacy, more benign side effect profile and potential to impact the longitudinal course of schizophrenia provide a rationale for the use novel antipsychotics as a first-line treatment of schizophrenia.

Original languageEnglish (US)
Pages (from-to)151-179
Number of pages29
JournalPsychiatric Clinics of North America
Volume21
Issue number1
DOIs
StatePublished - Jan 1 1998

All Science Journal Classification (ASJC) codes

  • Psychiatry and Mental health

Fingerprint Dive into the research topics of 'Emerging roles for novel antipsychotic medications in the treatment of schizophrenia'. Together they form a unique fingerprint.

Cite this